ALMU · Aeluma, Inc. · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-10-12 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2026. Reflects the weighted average price of 100,000 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on October 12, 2026 with sale prices ranging from $10.31 to $11.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
(I)
|
100,000 |
| 2026-09-30 | Stewart Christopher P. |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Includes 41,250 additional shares issuable upon vesting and settlement of existing RSUs that were previously reported in Table II. |
Common Stock
|
5,697 |
| 2026-09-21 | Klamkin Jonathan |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Stock award in lieu of cash bonus. |
Common Stock
|
12,675 |
| 2026-09-21 | Klamkin Jonathan |
Director, Chief Executive Officer |
Tax↓
|
Common Stock
|
4,547 |
| 2026-09-21 | Stewart Christopher P. |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock units ("RSUs") scheduled to vest and settle into an equal number of shares of common stock with respect to 25% of the shares on September 30, 2027 and thereafter in 12 substantially equivalent quarterly increments on the last day of each calendar quarter. |
Common Stock
|
15,886 |
| 2026-09-21 | Byron Michael |
Director |
Convert↑
|
Common Stock
|
25,000 |
| 2026-09-21 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Indirect)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2026. Reflects the weighted average price of 100,000 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on September 21, 2026 with sale prices ranging from $12.70 to $13.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
(I)
|
100,000 |
| 2026-09-21 | Stewart Christopher P. |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Stock award in lieu of cash bonus. |
Common Stock
|
4,042 |
| 2026-09-21 | Stewart Christopher P. |
Chief Financial Officer |
Tax↓
|
Common Stock
|
1,450 |
| 2026-09-21 | Byron Michael |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
Fully vested. |
Stock Option (right to buy)
|
25,000 |
| 2026-09-21 | Stewart Christopher P. |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Stock options scheduled to vest with respect to 25% of the shares on first anniversary of the grant date, and thereafter in 36 substantially equivalent increments on each monthly anniversary of the grant date. |
Stock Option (right to buy)
|
37,568 |
| 2026-09-21 | Klamkin Jonathan |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock units ("RSUs") scheduled to vest and settle into an equal number of shares of common stock with respect to 25% of the shares on September 30, 2027 and thereafter in 12 substantially equivalent quarterly increments on the last day of each calendar quarter. |
Common Stock
|
31,771 |
| 2026-09-21 | Klamkin Jonathan |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Stock options scheduled to vest with respect to 25% of the shares on first anniversary of the grant date, and thereafter in 36 substantially equivalent increments on each monthly anniversary of the grant date. |
Stock Option (right to buy)
|
75,135 |
| 2026-08-27 | Denbaars Steven |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025. The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.59 to $14.35, inclusive. |
Common Stock
|
12,500 |
| 2026-08-26 | Denbaars Steven |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025. The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.57 to $14.40, inclusive. |
Common Stock
|
12,500 |
| 2026-08-03 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↑
|
Common Stock
|
20,000 |
| 2026-08-03 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 15,810 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on August 3, 2026 with sale prices ranging from $16.62 to $17.53 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
15,810 |
| 2026-08-03 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↓
|
Common Stock
(I)
|
20,000 |
| 2026-08-03 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 4,190 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on August 3, 2026 with sale prices ranging from $15.62 to $16.61 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
4,190 |
| 2026-07-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↓
|
Common Stock
(I)
|
20,000 |
| 2026-07-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. |
Common Stock
|
100 |
| 2026-07-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↑
|
Common Stock
|
20,000 |
| 2026-07-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 19,900 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on July 1, 2026 with sale prices ranging from $20.54 to $21.52 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
19,900 |
| 2026-06-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 8,200 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on June 1, 2026 with sale prices ranging from $25.79 to $26.71 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
8,200 |
| 2026-06-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↓
|
Common Stock
(I)
|
20,000 |
| 2026-06-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 1,400 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on June 1, 2026 with sale prices ranging from $22.74 to $23.70 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
1,400 |
| 2026-06-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↑
|
Common Stock
|
20,000 |
| 2026-06-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 1,600 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on June 1, 2026 with sale prices ranging from $24.76 to $25.73 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
1,600 |
| 2026-06-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 7,900 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on June 1, 2026 with sale prices ranging from $23.75 to $24.74 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
7,900 |
| 2026-06-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 900 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on June 1, 2026 with sale prices ranging from $21.64 to $22.62 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
900 |
| 2026-05-20 | Denbaars Steven |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025. The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $20.907 to $21.63, inclusive. |
Common Stock
|
942 |
| 2026-05-20 | Denbaars Steven |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025. The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $19.89 to $20.8895, inclusive. |
Common Stock
|
11,558 |
| 2026-05-19 | Denbaars Steven |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025. Restricted stock units scheduled to vest with respect to approximately 1/12 of the shares on December 31, 2025, 1/4 of the shares on March 31, June 30, and September 30, 2026, and 1/6 of the shares on November 30, 2026. The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $19.02 to $20.01, inclusive. |
Common Stock
|
7,415 |
| 2026-05-19 | Denbaars Steven |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025. The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $20.0244 to $20.9963, inclusive. |
Common Stock
|
5,085 |
| 2026-05-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 15,024 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on May 1, 2026 with sale prices ranging from $24.62 to $25.61 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
15,024 |
| 2026-05-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↑
|
Common Stock
|
20,000 |
| 2026-05-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↓
|
Common Stock
(I)
|
20,000 |
| 2026-05-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 4,300 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on May 1, 2026 with sale prices ranging from $23.62 to $24.61 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
4,300 |
| 2026-05-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 676 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on May 1, 2026 with sale prices ranging from $25.62 to $26.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Due to interim sales transactions previously reported on March 6, 2026 and April 3, 2026, amounts of securities beneficially owned following reported transactions may not foot. |
Common Stock
|
676 |
| 2026-04-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 20,000 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on April 1, 2026 with sale prices ranging from $12.82 to $13.325 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
20,000 |
| 2026-04-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↓
|
Common Stock
(I)
|
20,000 |
| 2026-04-01 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↑
|
Common Stock
|
20,000 |
| 2026-03-04 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↑
|
Common Stock
|
50,000 |
| 2026-03-04 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 28,206 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on March 4, 2026 with sale prices ranging from $17.11 to $18.10 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
28,206 |
| 2026-03-04 | Klamkin Jonathan |
Director, Chief Executive Officer |
Gift↓
|
Common Stock
(I)
|
50,000 |
| 2026-03-04 | Klamkin Jonathan |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Reflects the weighted average price of 21,794 shares of common stock of Aeluma, Inc. sold by the reporting person in multiple transactions on March 4, 2026 with sale prices ranging from $18.11 to $19.03 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
21,794 |
| 2026-02-26 | Denbaars Steven |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025. The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.475 to $16.41, inclusive. |
Common Stock
|
12,500 |
| 2026-02-25 | Denbaars Steven |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025. The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $17.11 to $17.97, inclusive. |
Common Stock
|
12,500 |
| 2026-02-04 | Tompkins Mark N. |
Insider |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.94 to $15.50, inclusive. |
Common Stock
|
5,956 |
| 2026-02-04 | Tompkins Mark N. |
Insider |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.94 to $14.91, inclusive. |
Common Stock
|
28,544 |